Fxtrans:Best Practices for translating Japanese regulatory submissions

Many medical device companies doing business in Japan rely on their Japanese affiliates to handle the creation of regulatory documentation, due to language and cultural considerations and the complexities of Japanese regulations. A problem with this approach is that U.S.-based companies often do not know exactly what was submitted to the government, which can have serious implications.

For more Information please click:Fxtrans Japanese Regulatory Submissions